Quantcast

Latest radiation therapy Stories

2014-03-24 08:29:37

LOS ANGELES, March 24, 2014 /PRNewswire/ -- Dermatologist, Dr. Peyman Ghasri, offers treatments for various types of skin cancer. Skin cancer is the most common type of cancer in the United States today. In fact, half of all those who live beyond 65 will suffer from some form of skin cancer. Early diagnosis offers the best prognosis for skin cancer treatment, but options are available to treat the various stages and types of cancer based on the patient's needs and the cancer's...

2014-03-21 12:24:19

The SRT-100(TM) and SRT-100 Vision(TM) are used to treat a host of dermatological and oncological conditions with low-energy radiation therapy BOCA RATON, Fla., March 21, 2014 /PRNewswire/ -- Frost & Sullivan has recognized Sensus Healthcare with the 2014 North American award for New Product Innovation Leadership. Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leveraging leading-edge technologies. The award...

2014-03-21 08:25:00

Leveraging Proprietary Mucoadhesive Polymer Hydrogel Technology to Expand Product Offerings; Seeking Global Marketing Partners NEW YORK, March 21, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) announced that it has advanced development of a new proprietary product, called ProctiGard(TM), for the treatment of radiation proctitis. Radiation proctitis ("RP") is a significant unmet medical need, with no well-established standard of care. It is estimated that there are...

2014-03-20 23:02:41

Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. Sacramento, CA (PRWEB) March 20, 2014 Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. The...

2014-03-20 12:28:30

The products have demonstrated safety, clinical efficacy, and potential for widespread adoption to treat a host of dermatological and oncological conditions MOUNTAIN VIEW, Calif., March 20, 2014 /PRNewswire/ -- Based on its recent analysis of the non-melanoma skin cancer therapy market, Frost & Sullivan recognizes Sensus Healthcare LLC with the 2014 North American Frost & Sullivan Award for New Product Innovation Leadership. Sensus uses a technique known as superficial radiation...

2014-03-19 23:32:06

Rumors Finally Put to Rest, Ahmad ‘Real’ Givens of ‘Real Chance of Love’ is a Survivor (PRWEB) March 19, 2014 This week marks the one year anniversary of the former ‘Real Chance of Love’ star, Ahmad ‘Real’ Givens devastating diagnosis of stage 4 colon cancer. He and his brothers (Kamal ‘Chance’ Givens and Micah Givens) who are also his group members, known as The Stallionaires are celebrating by releasing their new single and video titled ‘I’m Bad’, a song that...

2014-03-18 12:31:04

Central Texas CyberKnife center marks nine years of cancer care AUSTIN, Texas, March 18, 2014 /PRNewswire/ -- Austin CyberKnife marks an important milestone in cancer care with the treatment of its 1,000th patient. University Medical Center Brackenridge, launched the CyberKnife program in 2005 and focused primarily on the treatment of brain tumors. Austin CyberKnife has since expanded the clinical applications of CyberKnife to treat other areas of the body, such as the lungs,...

2014-03-18 08:33:40

CAMBRIDGE, Mass., March 18, 2014 /PRNewswire/ -- Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2 trial designed to (1) identify the recommended Phase 2 dose of CRLX101 in combination with Xeloda(®) (capecitabine) and radiation (chemoradiotherapy) and (2) detect signals, if any, of increased efficacy over standard neoadjuvant chemoradiotherapy for rectal cancer. The trial is...

2014-03-13 20:24:05

DUBLIN, March 13, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/w548d6/us_proton_therapy) have announced the addition of the "Concise Analysis of the US Proton Therapy Market" [http://www.researchandmarkets.com/research/w548d6/us_proton_therapy ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) According to most Oncologists, about 60% of all cancer patients undergo some sort of...

2014-03-13 16:28:44

DUBLIN, March 13, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/8rl45x/us_proton_therapy) have announced the addition of the "US Proton Therapy Outlook 2017" [http://www.researchandmarkets.com/research/8rl45x/us_proton_therapy ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Physicians, in the face of an alarmingly rising incidences of cancer and limited treatment options are being...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related